Yayınlar & Eserler

Yayın Ağı
Makaleler 105
Tümü (105)
SCI-E, SSCI, AHCI (102)
SCI-E, SSCI, AHCI, ESCI (103)
ESCI (1)
Scopus (103)
TRDizin (13)
Diğer Yayınlar (1)

1. Evaluation of serum total antioxidant level, nutritional status and Mediterranean diet adherence of adult women with rheumatoid arthritis: a case-control study

BEKAR C., ARMAĞAN B., SARI A., AYAZ A.
BRITISH JOURNAL OF NUTRITION , sa.2, ss.239-245, 2025 (SCI-Expanded, Scopus) identifier identifier

2. The impact of histopathological criteria for definite vasculitis in giant cell arteritis: retrospective analysis of temporal artery biopsies

Uzun G. S., GÖKÖZ Ö., ÖĞÜT B., HEPER A., Guresci S., KARDAŞ R. C., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.44, ss.2547-2554, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

3. ALMOST TWO AND HALF PRECENTAGE OF RA PATIENTS HAD DIFFICULT TO TREAT (D2T): RESULTS FROM E.PULSE, THE NATIONWIDE HEALTH DATA

Ayan G., Karabulut E., Satis H., ERDEN A., Bilgin E., Armagan B., et al.
ANNALS OF THE RHEUMATIC DISEASES , 2024 (SCI-Expanded, Scopus) identifier

4. REMARKING THE OSTEOPOROSIS IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS (AAV): DATA FROM EASTERN MEDITERRANEAN (TRVAS)

Yildirim T. D., Erpek E., Ulusoy B. O., Unaldi E., Cagdas O. S., Kardas R. C., et al.
ANNALS OF THE RHEUMATIC DISEASES , 2024 (SCI-Expanded, Scopus) identifier

5. COMORBIDITIES IN 40.643 PSORIATIC ARTHRITIS PATIENTS ACCORDING TO GENDER: RESULTS FROM E.PULSE, THE NATIONWIDE HEALTH DATA

Kalyoncu U., Satis H., Ayan G., Bilgin E., ERDEN A., Armagan B., et al.
ANNALS OF THE RHEUMATIC DISEASES , 2024 (SCI-Expanded, Scopus) identifier

6. DEMOGRAPHIC CHARACTERISTICS, COMORBIDITIES AND TREATMENT CHOICES OF EARLY AND LATE ONSET RA PATIENTS: RESULTS FROM E.PULSE,THE NATIONWIDE HEALTH DATA

Kucuksahin O., Satis H., Karabulut E., Ayan G., ERDEN A., Bilgin E., et al.
ANNALS OF THE RHEUMATIC DISEASES , 2024 (SCI-Expanded, Scopus) identifier

7. OFF-LABEL USE OF BIOLOGICS AND SMALL MOLECULES IN SJÖGREN DISEASE: REAL-WORLD DATA FROM THE INTERNATIONAL SJÖGREN BIG DATA COHORT

Quartuccio L., Brito-Zeron P., Rischmueller M., Lee A. Y. S., Trevisani V. F. M., Pasoto S., et al.
ANNALS OF THE RHEUMATIC DISEASES , 2024 (SCI-Expanded, Scopus) identifier

8. Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS)

BİLGİN E., Demirci Yıldırım T., Özdemir Ulusoy B., Öğüt T. S., Karabacak M., Sadioğlu Çağdaş Ö., et al.
Internal and Emergency Medicine , 2024 (SCI-Expanded, Scopus) identifier identifier identifier

9. Influence of exposure to climate-related hazards in the phenotypic expression of primary Sjögren's syndrome

Flores-Chavez A., Brito-Zeron P., Ng W. -., Szanto A., Rasmussen A., Priori R., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.41, sa.12, ss.2437-2447, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

10. Exposure to air pollution as an environmental determinant of how Sjögren's disease is expressed at diagnosis

Brito-Zeron P., Flores-Chavez A., Ng W. -., Horvath I. F., Rasmussen A., Priori R., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.41, sa.12, ss.2448-2457, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

11. Does decision tree analysis predict oral ulcer activity-related factors in patients with Behçet's syndrome?

Çandereli Z. Ö., Arslan T., Özdamar Ö., Yay M., Karaçayli Ü., Şişman-Kitapçi N., et al.
Clinical and experimental rheumatology , cilt.41, sa.10, ss.2078-2086, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

12. Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study

Ates I., Batirel A., Aydin M., Karadag F. Y., Erden A., KÜÇÜKŞAHİN O., et al.
Vaccines , cilt.11, sa.7, 2023 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

13. Mortality risk factors in primary Sjögren syndrome: a real-world, retrospective, cohort study

Brito-Zerón P., Flores-Chávez A., Horváth I. F., Rasmussen A., Li X., Olsson P., et al.
eClinicalMedicine , cilt.61, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

14. Association between oxygen delivery and digital ulcers in systemic sclerosis

AKDOĞAN A., Sari A., Sener Y. Z., Oksul M., Armagan B., KILIÇ L., et al.
Microvascular Research , cilt.145, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

15. Pulmonary hypertension in Behçet’s disease: echocardiographic screening and multidisciplinary approach

ARMAĞAN B., OKŞUL M., ŞENER Y. Z., SARI A., ERDEN A., YARDIMCI G. K., et al.
Turkish Journal of Medical Sciences , cilt.53, sa.2, ss.563-571, 2023 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier identifier

16. The impact of antiphospholipid antibodies in Takayasu arteritis

Firat Şentürk E., ERDEN A., SARI A., ARMAĞAN B., KILIÇ L., KALYONCU U., et al.
Turkish Journal of Medical Sciences , cilt.53, sa.1, ss.199-205, 2023 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier identifier

17. Drug retention rate and predictive factors of drug survival for secukinumab in radiographic axial spondyloarthritis

Armagan B., KILIÇ L., Farisogullari B., YARDIMCI G. K., Bilgin E., BÖLEK E. Ç., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.43, sa.1, ss.147-156, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

18. Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies

Hernandez-Molina G., Kostov B., Brito-Zeron P., Vissink A., Mandl T., Hinrichs A. C., et al.
RHEUMATOLOGY , cilt.62, ss.243-255, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

19. Quality of life, disease activity and preferences for administration routes in rheumatoid arthritis: a multicentre, prospective, observational study

DİRESKENELİ R. H., KARADAĞ Ö., ATEŞ A., TUFAN A., Inanc N., KOCA S. S., et al.
RHEUMATOLOGY ADVANCES IN PRACTICE , cilt.6, sa.3, 2022 (ESCI, Scopus) Creative Commons License identifier identifier identifier

20. Antibodies to Both Ro52 and Ro60 for Identifying Sjogren's Syndrome Patients Best Suited for Clinical Trials of Disease-Modifying Therapies

ARMAĞAN B., Robinson S. A., Bazoberry A., Perin J., Grader-Beck T., Akpek E. K., et al.
ARTHRITIS CARE & RESEARCH , cilt.74, sa.9, ss.1559-1565, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

21. IS IT TIME TO DISSECTING GIANT CELL ARTERITIS INTO SUBPHENOTYPES? A CLOSE LOOK TO DATA OF EASTERN MEDITERRANEAN VASCULITIS CENTRE

Uzun G. S., Gokoz O., Tahillioglu Y., Sadigh S. L., Tan A. A., Ardali S., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1422, 2022 (SCI-Expanded, Scopus) Creative Commons License identifier

22. Pleuroparenchymal fibroelastosis in systemic sclerosis-associated interstitial lung disease

SARI A., ÖNDER Ö., ARMAĞAN B., BÖLEK E. Ç., Farisogullari B., BİLGİN E., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.52, sa.1, ss.83-88, 2022 (SCI-Expanded, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier identifier

23. TRENDS IN THE CHOICE OF FIRST BIOLOGIC AND TARGETED SYNTHETIC DMARD IN RHEUMATOID ARTHRITIS PATIENTS: 20-YEARS JOURNEY OF HURBIO REAL-LIFE REGISTRY

Ertenli A. I., Kalyoncu U., Karadag O., Kilic L., Akdogan A., Dogan I., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.1124, 2021 (SCI-Expanded, Scopus) Creative Commons License identifier

24. CHANGES IN THE PRESCRIPTION PATTERNS OF THE SECOND-LINE BIOLOGIC AND TARGETED SYNTHETIC DMARD IN RHEUMATOID ARTHRITIS PATIENTS: 20-YEARS JOURNEY OF HUR-BIO REAL-LIFE REGISTRY

Kiraz S., Kalyoncu U., Karadag O., Kilic L., Akdogan A., Dogan I., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.1124-1125, 2021 (SCI-Expanded, Scopus) Creative Commons License identifier

25. PRESCRIPTION PATTERNS OF THE SECOND BIOLOGIC DMARD IN PSORIATIC ARTHRITIS THROUGH THE LAST DECADE: HURBIO-PsA REAL LIFE EXPERIENCE

Kalyoncu U., Karadag O., Kilic L., Akdogan A., Dogan I., Bilgen S. A., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.1299, 2021 (SCI-Expanded, Scopus) Creative Commons License identifier

26. Evaluating skeletal muscle mass with ultrasound in patients with systemic sclerosis

SARI A., EŞME M., ŞENGÜL AYÇİÇEK G., ARMAĞAN B., KILIÇ L., ERTENLİ A. İ., et al.
NUTRITION , cilt.84, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

27. Phenotypic characterization of Familial Mediterranean Fever patients harboring variants of uncertain significance

SARI A., BODAKÇİ E., ARMAĞAN B., SATIŞ H., Atas N., YAŞAR BİLGE N. Ş., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.4, ss.1695-1701, 2021 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier identifier

28. How did the updated hemodynamic definitions affect the frequency of pulmonary hypertension in patients with systemic sclerosis?

SARI A., ŞENER Y. Z., ARMAĞAN B., KILIÇ L., KAYA E. B., HEKİMSOY V., et al.
ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.25, sa.1, ss.30-35, 2021 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

29. Appendectomy history is associated with severe disease and colchicine resistance in adult familial Mediterranean fever patients

BODAKÇİ E., YAŞAR BİLGE N. Ş., AtaS N., ARMAĞAN B., SATIŞ H., SARI A., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.4, ss.1706-1711, 2021 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier identifier

30. Predictors of persistent inflammation in familial Mediterranean fever and association with damage

Babaoglu H., ARMAĞAN B., BODAKÇİ E., SATIŞ H., Atas N., SARI A., et al.
RHEUMATOLOGY , cilt.60, sa.1, ss.333-339, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

31. Moderation analysis exploring associations between age and mucocutaneous activity in Behcet's syndrome: A multicenter study from Turkey

MUMCU G., Yay M., Karacayli U., Aksoy A., Tas M. N., ARMAĞAN B., et al.
JOURNAL OF DERMATOLOGY , cilt.47, sa.12, ss.1403-1410, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

32. Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjogren's syndrome

Brito-Zeron P., Acar-Denizli N., Ng W., Horvath I. F., Rasmussen A., Seror R., et al.
RHEUMATOLOGY , cilt.59, sa.9, ss.2350-2359, 2020 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

33. Predictors of drug retention and treatment response in axial spondyloarthritis patients treated with certolizumab: real-life results from the HURBIO registry

Bilgin E., Farisogullari B., Armagan B., Sari A., Yardimci G. K., Bolek E. C., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.38, sa.4, ss.609-614, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

34. Predictive factors for work-day loss in Behcet's syndrome: A multi-center study

MUMCU G., Yay M., Aksoy A., Tas M. N., ARMAĞAN B., SARI A., et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.23, sa.2, ss.240-246, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

35. Geoepidemiology and clinical characteristics of neonatal lupus erythematosus: a systematic literature review of individual patients' data

ERDEN A., Fanouriakis A., KILIÇ L., SARI A., ARMAĞAN B., BİLGİN E., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.50, sa.2, ss.281-290, 2020 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier

36. Systemic phenotype related to primary Sjogren's syndrome in 279 patients carrying isolated anti-La/SSB antibodies

Acar-Denizli N., Horvath I. -., Mandl T., Priori R., Vissink A., Hernandez-Molina G., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.38, sa.4, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

37. Familial Mediterranean fever is associated with a wide spectrum of inflammatory disorders: results from a large cohort study

Atas N., ARMAĞAN B., Bodakci E., Satis H., SARI A., Bilge N. S. Y., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.40, sa.1, ss.41-48, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

38. Anti-interleukin-6 (tocilizumab) therapy in Takayasu's arteritis: a real life experience

KILIÇ L., KARADAĞ Ö., Erden A., SARI A., ARMAĞAN B., YARDIMCI G. K., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.50, sa.1, ss.31-36, 2020 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier

39. Colchicine intolerance in FMF patients and primary obstacles for optimal dosing

Satis H., ARMAĞAN B., Bodakci E., Atas N., SARI A., Yasar Bilge N. S., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.50, sa.5, ss.1337-1343, 2020 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

40. Autoimmune congenital heart block and primary Sjogren's syndrome: characterisation and outcomes of 49 cases

Brito-Zeron P., Pasoto S. G., Robles-Marhuenda A., Mandl T., Vissink A., Armagan B., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.38, sa.4, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

41. Familial Mediterranean fever-associated infertility and underlying factors

Atas N., ARMAĞAN B., Bodakci E., Satis H., SARI A., Bilge N. S. Y., et al.
CLINICAL RHEUMATOLOGY , cilt.39, sa.1, ss.255-261, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

42. Target Organ Associations in Polyarteritis Nodosa (PAN): Results of a Worldwide Collaboration Study

KARADAĞ Ö., Furuta S., Hocevar A., Gazel U., Hinojosa-Azaola A., UĞURLU S., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.71, 2019 (SCI-Expanded, Scopus) identifier

43. Retention Rates and Response of Anti-TNF Treatments in the Enteropathic Spondylitis: HUR-BIO Real Life Results

YARDIMCI G. K., Farisogullari B., SARI A., KILIÇ L., ARMAĞAN B., BİLGİN E., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.71, 2019 (SCI-Expanded, Scopus) identifier

44. Temporal Relationship Between Enteropathic Spondylitis Symptoms/diagnosis and Inflammatory Bowel Diseases Diagnosis: HUR-BIO Real Life Results

Farisogullari B., YARDIMCI G. K., SARI A., ARMAĞAN B., BİLGİN E., BÖLEK E. Ç., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.71, 2019 (SCI-Expanded, Scopus) identifier

45. Mortality Ratio and Risk Factors in CT Confirmed Rheumatoid Arthritis Related Lung Disease: UIP, Pleural Effusion and the Time of Diagnosis of Rheumatoid Arthritis - Lung Disease

EKİCİ M., SARI A., BAYTAR Y., BÖLEK E. Ç., ARMAĞAN B., BİLGİN E., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.71, 2019 (SCI-Expanded, Scopus) identifier

46. Are There Phenotypic Overlaps Between Giant Cell Arteritis Subgroups?

ARMAĞAN B., YILDIRIM A., SARI A., Farisogullari B., BİLGİN E., KILIÇ L., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.71, 2019 (SCI-Expanded, Scopus) identifier

47. Systemic Manifestations of Primary Sjogren Syndrome out of the ESSDAI Classification: Prevalence and Clinical Relevance in a Large International, Multi-ethnic Cohort of Patients

Retamozo S., Acar-Denizli N., Rasmussen A., Horvath I. F., Baldini C., Priori R., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.71, 2019 (SCI-Expanded, Scopus) identifier

48. Periaortitis and Coronary Arteritis in IgG4-Related Disease: Eastern Mediterranean Experience

YARDIMCI G. K., SARI A., Erden A., BÖLEK E. Ç., Farisogullari B., KILIÇ L., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.71, 2019 (SCI-Expanded, Scopus) identifier

49. Increased incidence of spondyloarthropathies in patients with Takayasu arteritis: a systematic clinical survey

Esen S. G., ARMAĞAN B., Atas N., UÇAR M., Varan O., ERDEN A., et al.
JOINT BONE SPINE , cilt.86, sa.4, ss.497-501, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

50. Proposal for a simple algorithm to differentiate adult-onset Still's disease with other fever of unknown origin causes: a longitudinal prospective study

BİLGİN E., Hayran M., Erden A., Armagan B., Sari A., KILIÇ L., et al.
CLINICAL RHEUMATOLOGY , cilt.38, sa.6, ss.1699-1706, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

51. Successful Treatment of Amyloid A-Type Amyloidosis Due to Behcet Disease With Tocilizumab

İLBAY A., ERDEN A., SARI A., ARMAĞAN B., AKTAŞ B. Y., BÖLEK E. Ç., et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , cilt.25, sa.4, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

52. Adalimumab as treatment for venous thrombosis in Behcet's syndrome: comment on the article by Emmi et al

Farisogullari B., SARI A., AYAR Ş. N., KILIÇ L., ARMAĞAN B., KARADAĞ Ö.
ARTHRITIS & RHEUMATOLOGY , cilt.71, sa.4, ss.657, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

53. Change in PsAID-12 scores in patients continuing or discontinuing anti-TNF treatments in psoriatic arthritis: results from the HUR-BIO biologic registry

KALYONCU U., KİRAZ S., APRAŞ BİLGEN Ş. Ş., KARADAĞ Ö., AKDOĞAN A., KILIÇ L., et al.
CLINICAL RHEUMATOLOGY , cilt.38, sa.4, ss.1187-1192, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

54. Frequency of Behcet's disease among a group of visually impaired adults

UYAROĞLU O. A., ŞEYHOĞLU E., ERDEN A., Vahabov C., BABAOĞLU H., ARMAĞAN B., et al.
IRISH JOURNAL OF MEDICAL SCIENCE , cilt.188, sa.1, ss.333-336, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

55. Capillaroscopic findings in Turkish Takayasu arteritis patients

AKDOĞAN A., ERDEN A., Firat Senturk E., KILIÇ L., SARI A., ARMAĞAN B., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.49, sa.5, ss.1303-1307, 2019 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier

56. Oral ulcer activity assessment with the composite index according to different treatment modalities in Behcet's syndrome: a multicentre study

Mumcu G., Karacayli U., Yay M., Aksoy A., Tas M. N., Armagan B., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.37, sa.6, ss.98-104, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

57. Systemic manifestations of primary Sjogren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients

Retamozo S., Acar-Denizli N., Rasmussen A., Horvath I. F., Baldini C., Priori R., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.37, sa.3, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

58. Polyarteritis nodosa: lessons from 25 years of experience

Sonmez H. E., Armagan B., Ayan G., Barut K., Batu E. D., Erden A., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.37, sa.2, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

59. Rituximab Therapy in Renal Amyloidosis Secondary to Rheumatoid Arthritis

KILIÇ L., ERDEN A., ŞENER Y. Z., ARMAĞAN B., SARI A., KALYONCU U., et al.
BIOMOLECULES , cilt.8, sa.4, 2018 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

60. Is the PET/CT first choice for differential diagnosis of fever of FUO/IUO?

ARMAĞAN B., ERDEN A., BEYDAŞ Ö., SARI A., KILIÇ L., KALYONCU U.
ANNALS OF THE RHEUMATIC DISEASES , cilt.77, sa.11, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

61. Comparing immunoglobulin A vasculitis (Henoch-Schonlein purpura) in children and adults: a single-centre study from Turkey

Batu E. D., Sari A., Erden A., Sonmez H. E., Armagan B., Kalyoncu U., et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY , cilt.47, sa.6, ss.481-486, 2018 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

62. Multi-Biologic Usage in Rheumatoid Arthritis Is Not Infrequent in the Routine Practice

SARI A., KILIÇ L., ARMAĞAN B., ERDEN A., Yardimci G., AKDOĞAN A., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus) identifier

63. Familial Mediterranean Fever Associated Infertility and Underlying Factors with Fertility

Atas N., ARMAĞAN B., Bodakci E., KAŞİFOĞLU T., Satis H., SARI A., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus) identifier

64. How Immunological Profile Drives Clinical Phenotype of Primary Sjogren's Syndrome at Diagnosis: Analysis of 10.500 Patients (Sjogren Big Data Project)

Retamozo S., Acar-Denizli N., Ng W., Zeher M., Rasmussen A., Mandl T., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus) identifier

65. Treatment Choices and Response Rates of SAPHO Syndrome: Single Center Case Series

ERDEN A., EKİCİ M., SARI A., ARMAĞAN B., KILIÇ L., APRAŞ BİLGEN Ş. Ş., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus) identifier

66. Clinical Features and Outcome of Patients with Polyarteritis Nodosa - a Global Collaborative Study

KARADAĞ Ö., Furuta S., Hocevar A., Gazel U., Gopaluni S., ARMAĞAN B., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus) identifier

67. Familial Mediterranean Fever Related Damage Assessed By Auto-Inflammatory Disease Damage Index (ADDI) and Associated Factors with Damage

TUFAN A., ARMAĞAN B., Bodakci E., KAŞİFOĞLU T., Satis H., Atas N., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus) identifier

68. Effectiveness of a Biopsychosocial Exercise Approach in Rheumatic Diseases

ÜNAL E., ARIN G., KARACA N. B., OFLAZ F. B., ÖZÇADIRCI A., ERDEN A., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus) identifier

69. Evaluation of Vitamin B12 Deficiency and Associated Factors in Patients With Systemic Sclerosis

Kilic D. T., AKDOĞAN A., KILIÇ L., SARI A., ERDEN A., ARMAĞAN B., et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , cilt.24, sa.5, ss.250-254, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

70. Pulmonary hypertension in Takayasu arteritis

SARI A., ŞENER Y. Z., Fira E., ARMAĞAN B., ERDEN A., OKŞUL M., et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.21, sa.8, ss.1634-1639, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

71. Some concerns and improvements from Turkey

ÇINAR O. E., ERDEN A., SARI A., ARMAĞAN B., KILIÇ L.
ANNALS OF THE RHEUMATIC DISEASES , cilt.77, sa.6, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

72. Blood group 'A' may have a possible modifier effect on familial Mediterranean fever and blood group '0' may be associated with colchicine resistance

ERDEN A., BATU AKAL E. D., ARMAĞAN B., SÖNMEZ H. E., SARI A., DEMİR S., et al.
BIOMARKERS IN MEDICINE , cilt.12, sa.6, ss.565-572, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

73. CLINICAL AND IMMUNOLOGICAL PRIMARY SJOGREN SYNDROME' DISEASE PATTERNS ARE DRIVEN BY GENDER AND AGE AT DIAGNOSIS

Retamozo S., Hernandez-Molina G., Valim V., Moca Trevisani V. F., Pasoto S. G., Acar-Denizli N., et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , cilt.24, 2018 (SCI-Expanded, Scopus) identifier

74. HOW ETHNICITY MODIFIES SYSTEMIC ACTIVITY OF PRIMARY SJOGREN SYNDROME: ANALYSIS OF BASELINE ESSDAI SCORES IN A MULTI-ETHNIC INTERNATIONAL COHORT

Retamozo S., Hernandez-Molina G., Valim V., Moca Trevisani V. F., Pasoto S. G., Acar-Denizli N., et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , cilt.24, 2018 (SCI-Expanded, Scopus) identifier

75. Aspergillus Pneumonia in a Patient With Adult-Onset Still Disease Successfully Treated With Anakinra

BİLGİN E., ERDEN A., KILIÇ L., SARI A., ARMAĞAN B., KALYONCU U., et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , cilt.24, sa.3, ss.156-158, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

76. SYSTEMIC SJOGREN PRESENTING WITHOUT SICCA SYNDROME: CHARACTERIZATION OF 240 PATIENTS ACCORDING TO THE NEW 2017 ACR/EULAR CLASSIFICATION CRITERIA

Retamozo S., Hernandez-Molina G., Valim V., Moca Trevisani V. F., Pasoto S. G., Acar-Denizli N., et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , cilt.24, 2018 (SCI-Expanded, Scopus) identifier

77. HOW DIFFERENT SYSTEMIC ORGAN INVOLVEMENTS OVERLAP IN PATIENTS WITH PRIMARY SJOGREN SYNDROME: ANALYSIS USING A MATHEMATICAL MODEL

Retamozo S., Hernandez-Molina G., Valim V., Moca Trevisani V. F., Pasoto S. G., Acar-Denizli N., et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , cilt.24, 2018 (SCI-Expanded, Scopus) identifier

78. Starting of biological disease modifying antirheumatic drugs may be postponed in rheumatoid arthritis patients with multimorbidity: Single center real life results

ARMAĞAN B., SARI A., ERDEN A., KILIÇ L., ERDAT E. C., KILIÇKAP S., et al.
MEDICINE , cilt.97, sa.13, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

79. Multiple liver masses mimicking metastatic liver disease in an elderly patient

KÖKLÜ H., ARMAĞAN B., KARADAĞ Ö., KARÇAALTINCABA M., ÖZGEN KIRATLI M. P., Gedikoglu G., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.29, sa.1, ss.119-122, 2018 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier

80. Systemic Sjogren presenting without sicca syndrome: characterization of 240 patients according to the new 2017 ACR/EULAR Classification Criteria

Retamozo S., Acar-Denizli N., Zeher M., Sivils K., Mandl T., Seror R., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.3, 2018 (SCI-Expanded, Scopus) identifier

81. Pulmonary Hypertension in Behcet's Disease

Armagan B., Oksul M., Sener Y. Z., Sari A., Erden A., Yardimci G. K., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.6, 2018 (SCI-Expanded, Scopus) identifier

82. Clinical and immunological disease patterns of primary Sjogren syndrome driven by gender and age at diagnosis

Retamozo S., Kostov B., Zeher M., Sivils K., Mandl T., Seror R., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.3, 2018 (SCI-Expanded, Scopus) identifier

83. Which definition should be used to determine colchicine resistance among patients with familial Mediterranean fever?

Erden A., Batu E. D., Sari A., Sonmez H. E., Armagan B., Demir S., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.6, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

84. Pazopanib-Induced Hepatotoxicity in an Experimental Rat Model

Cetin B., Yilmaz G. E., ARMAĞAN B., AFŞAR B., Demirci U., GÜLBAHAR Ö., et al.
CHEMOTHERAPY , cilt.63, sa.1, ss.39-45, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

85. Increased psoriasis frequency in patients with familial Mediterranean fever

ERDEN A., BATU AKAL E. D., ŞEYHOĞLU E., SARI A., SÖNMEZ H. E., ARMAĞAN B., et al.
UPSALA JOURNAL OF MEDICAL SCIENCES , cilt.123, sa.1, ss.57-61, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

86. How ethnicity modifies systemic activity of primary Sjogren syndrome: analysis of baseline ESSDAI scores in a multi-ethnic international cohort

Retamozo S., Kostov B., Zeher M., Sivils K., Mandl T., Seror R., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.3, 2018 (SCI-Expanded, Scopus) identifier

87. How immunological profile drives clinical phenotype of primary Sjogren's syndrome at diagnosis: analysis of 10,500 patients (Sjogren Big Data Project)

Brito-Zeron P., Acar-Denizli N., Ng W. F., Zeher M., Rasmussen A., Mandl T., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.3, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

88. How the different systemic organ involvements are overlapped in patients with primary Sjogren syndrome: analysis using a mathematical model

Retamozo S., Kostov B., Zeher M., Sivils K., Mandl T., Seror R., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.3, 2018 (SCI-Expanded, Scopus) identifier

89. ANKİLOZAN SPONDİLİT HASTALARINDA HASTALIK AKTİVİTESİ VE FONKSİYONELLİK ARASINDAKİ İLİŞKİNİN İNCELENMESİ

ARIN G., KARACA N. B., OFLAZ F. B., SARI A., ARMAĞAN B., KALYONCU U., et al.
Journal of Exercise Therapy and Rehabilitation , cilt.4, sa.3, 2017 (Hakemli Dergi)

90. Rituximab Experience in Patients With Long-standing Systemic Sclerosis-Associated Interstitial Lung Disease: A Series of 14 Patients

SARI A., Guven D., ARMAĞAN B., ERDEN A., KALYONCU U., KARADAĞ Ö., et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , cilt.23, sa.8, ss.411-415, 2017 (SCI-Expanded, Scopus) identifier identifier identifier

91. Patients with Ankylosing Spondylitis Had Better Adalimumab Survival Than Patients with Non-Radiographic Axial Spondyloarthritis

SARI A., ARMAĞAN B., ERDEN A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.69, 2017 (SCI-Expanded, Scopus) identifier

92. Requirement and Response Rates of Biologic Agents in Polyarteritis Nodosa (PAN)

Karadag O., ARMAĞAN B., ERDEN A., Gopaluni S., SARI A., KİRAZ S., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.69, 2017 (SCI-Expanded, Scopus) identifier

93. Older Age and Male Gender Are Independent Predictors of Quantiferon Positivity Among Adult Rheumatic Patients in a Tertiary Care Center from a BCG Vaccinated Country: Hur-BIO Single Center Real Life Results

ŞEYHOĞLU E., UYAROĞLU O. A., ERDEN A., KILIÇ L., ARMAĞAN B., SARI A., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.69, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

94. Starting of Biological Dmards May be Postponed in RA Patients with Multimorbidity: Single Centre Real Life Results

ARMAĞAN B., SARI A., ERDEN A., KILIÇ L., ERDAT E. C., KARADAĞ Ö., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.69, 2017 (SCI-Expanded, Scopus) identifier

95. Blood Group "a" Was Increased in FMF Patients and Blood Group "0" May be Associated with Colchicine Resistance

ERDEN A., BATU AKAL E. D., ARMAĞAN B., SÖNMEZ H. E., SARI A., DEMİR S., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.69, 2017 (SCI-Expanded, Scopus) identifier

96. Active Disease Is Associated with Dependency in Inflammatory Arthritis

Durmaz H. O., SARI A., ARMAĞAN B., ERDEN A., KILIÇ L., Karadag O., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.69, 2017 (SCI-Expanded, Scopus) identifier

97. Which Definition Should be Used to Determine Colchicine Resistance in Patients with Familial Mediterranean Fever?

ERDEN A., BATU AKAL E. D., SARI A., SÖNMEZ H. E., ARMAĞAN B., DEMİR S., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.69, 2017 (SCI-Expanded, Scopus) identifier

98. Pregnancy Outcomes in Male Patients Using Anti-Tumor Necrosis Factor Alpha Patients with Inflammatory Arthritis; Hur-BIO Real Life Experiences

UYAROĞLU O. A., ŞEYHOĞLU E., ERDEN A., KILIÇ L., ARMAĞAN B., SARI A., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.69, 2017 (SCI-Expanded, Scopus) identifier

99. A Retrospective Study Comparing the Phenotype and Outcomes of Patients with Polyarteritis Nodosa between UK and Turkish Cohorts

Karadag O., ERDEN A., BİLGİNER Y., Gopaluni S., SARI A., ARMAĞAN B., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.69, 2017 (SCI-Expanded, Scopus) identifier identifier

100. Comparing polyarteritis nodosa in children and adults: a single center study

ERDEN A., BATU AKAL E. D., SÖNMEZ H. E., SARI A., ARMAĞAN B., ARICI Z. S., et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.20, sa.8, ss.1016-1022, 2017 (SCI-Expanded, Scopus) identifier identifier identifier

101. Retention Rate of Etanercept in Patients with Rheumatoid Arthritis Is Better Than That of Monoclonal Antibody

ERDEN A., KILIÇ L., KARADAĞ Ö., KİRAZ S., KILIÇKAP S., AKDOĞAN A., et al.
Acta Medica , cilt.48, sa.3, ss.11-17, 2017 (TRDizin)

102. The clinical features and outcomes of Turkish patients with IgG4-related disease: a single-center experience

KARADAĞ Ö., Erden A., AYHAN E. A., BÖLEK E. Ç., KALYONCU U., ARMAĞAN B., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.47, sa.5, ss.1307-1314, 2017 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

103. The Characteristic Features of the Patients with Deficiency of Adenosine Deaminase 2 (DADA2)

ERDEN A., BATU AKAL E. D., Taskiran E. Z., SÖNMEZ H. E., SARI A., ARMAĞAN B., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded, Scopus) identifier

104. Obesity Is Related with Active State in Psoriatic Arthritis and Rheumatoid Arthritis but Not Ankylosing Spondylitis at Real Life Biological Cohort

KALYONCU U., KILIÇ L., ERDEN A., SARI A., ARMAĞAN B., KARADAĞ Ö., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

105. Cytomegalovirus (CMV) Infections in Patients with Rheumatic Diseases: Experience of a Referral Center

ŞENER Y. Z., AKTAŞ B. Y., Erden A., KILIÇ L., Armagan B., İNKAYA A. Ç., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus) identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 78

1. PERFORMANCE OF 2022 ACR/EULAR GPA, EGPA AND MPA CLASSIFICATION CRITERIA IN TURKISH VASCULITIS STUDY GROUP PROSPECTIVE COHORT (TRVAS)

Bolek E. C., AYAN G., BİLGİN E., Ediboglu E. D., Duran E., Kardas C., et al.
European Congress of Rheumatology (EULAR), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, ss.1597-1598, (Özet Bildiri) Creative Commons License Sürdürülebilir Kalkınma identifier

2. CONCOMITANT PSORIATIC ARTHRITIS AND INFLAMMATORY BOWEL DISEASE IN THE PSA BIOLOGICAL REGISTRY: HUR-BIO REAL LIFE RESULTS

Yardimci G. K., Farisogullari B., Armagan B., Bilgin E., Bolek E. C., Duran E., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1174-1175, (Özet Bildiri) identifier

3. SECUKINUMAB IS FREQUENTLY PREFERRED IN MULTI ANTI-TNF RESISTANCE SPONDYLOARTHRITIS PATIENTS: HUR-BIO REAL LIFE RESULTS

Armagan B., Kilic L., Yardimci G. K., Bilgin E., Farisogullari B., Bolek E. C., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.419-420, (Özet Bildiri) Creative Commons License identifier

4. FACTORS RELATED TO RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RHEUMATOID ARTHRITIS-RELATED INTERSTITIAL LUNG DISEASE

Kalyoncu U., Ekici M., Bilgin E., Sari A., Baytar Y., Bolek E. C., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1394, (Özet Bildiri) Creative Commons License identifier

5. CAN FECAL CALPROTECTIN PREDICT FUTURE DEVELOPMENT OF INFLAMMATORY BOWEL DISEASE IN AXIAL SPONDYLOARTHRITIS PATIENTS? - TREASURE REAL-LIFE DATA

Yardimci G. K., Icacan O. C., Kabadayi G., Farisogullari B., Armagan B., Bes C., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1142-1143, (Özet Bildiri) Creative Commons License identifier

6. COLCHICINE INTOLERANCE IN FMF PATIENTS AND PRIMARY OBSTACLES FOR OPTIMAL DOSING

Satis H., Armagan B., Bodakci E., Atas N., Sari A., Yapar D., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.848, (Özet Bildiri) Creative Commons License identifier

7. REAL-LIFE EXPERIENCE FOR SECUKINUMAB IN PSORIATIC ARTHRITIS FROM HURBIO-PSA DATABASE

Bolek E. C., Bilgin E., Yardimci G. K., Farisogullari B., Duran E., Armagan B., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1665-1666, (Özet Bildiri) Creative Commons License identifier

8. ANEURYSM IN BEHCET'S DISEASE: MANAGEMENT, PROGNOSIS AND MORTALITY

ARMAĞAN B., BÖLEK E. Ç., SARI A., YARDIMCI G. K., Farisogullari B., BİLGİN E., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.422, (Özet Bildiri) Creative Commons License identifier

9. ENTEROPATHIC ARTHRITIS PATIENTS UNDER BDMARD TREATMENTS HAD FREQUENTLY RADIOGRAPHIC SACROILIITIS: HUR-BIO REAL LIFE RESULTS

YARDIMCI G. K., Farisogullari B., SARI A., KILIÇ L., ARMAĞAN B., BİLGİN E., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.478, (Özet Bildiri) Creative Commons License identifier

10. LYMPHOMA ARISING AT THE TIME OF DIAGNOSIS OF PRIMARY SJOGREN SYNDROME: A HIGHLY-ACTIVE SYSTEMIC SUBSET OF THE DISEASE

Retamozo S., Acar-Denizli N., Wan Fai Ng W. F. N., Szanto A., Rasmussen A., Seror R., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.138, (Özet Bildiri) identifier

11. IMMUNE-RELATED ADVERSE EVENTS INDUCED BY CANCER IMMUNOTHERAPIES. BIG DATA ANALYSIS OF 13,051 CASES (IMMUNOCANCER INTERNATIONAL REGISTRY)

Ramos-Casals M., Lambotte O., Kostine M., Calabrese L., Suarez-Almazor M., Bingham C., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.607-608, (Özet Bildiri) Creative Commons License Sürdürülebilir Kalkınma identifier

12. HOW THE AGE AT DIAGNOSIS MODIFIES THE PHENOTYPE OF PRIMARY SJOGREN SYNDROME: ANALYSIS IN 11,420 PATIENTS (BIG DATA SJOGREN PROJECT)

Retamozo S., Acar-Denizli N., Ng W. F., Horvath I. F., Rasmussen A., Seror R., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.416-417, (Özet Bildiri) Creative Commons License identifier

13. COMPARISON OF SURVIVAL RATES AMONG SUBGROUPS OF PATIENTS EVALUATED FOR FEVER OF UNKNOWN ORIGIN

BİLGİN E., ARMAĞAN B., SARI A., BÖLEK E. Ç., Farisogullari B., YARDIMCI G. K., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.573, (Özet Bildiri) Creative Commons License identifier

14. PREVALENCE, UNDERLYING FACTORS AND DAMAGE ASSOCIATED WITH CHRONIC PERSISTENT INFLAMMATION IN PATIENTS WITH FMF

BABAOĞLU H., ARMAĞAN B., Bodakci E., KAŞİFOĞLU T., Satis H., Atas N., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.571-572, (Özet Bildiri) Creative Commons License identifier

15. PHENOTYPE OF BIOPSY-PROVEN PATIENTS WITH PRIMARY SJOGREN SYNDROME LACKING RO AUTOANTIBODIES: HIGH FREQUENCY OF DRYNESS SYMPTOMS WITH LOW SYSTEMIC ACTIVITY (BIG DATA SJOGREN PROJECT)

Retamozo S., Acar-Denizli N., Ng W. F., Horvath I. F., Rasmussen A., Seror R., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1736-1737, (Özet Bildiri) Creative Commons License identifier

16. ANTIBODIES TO BOTH RO52 AND RO60 DEFINE A SUBSET OF SJOGREN'S MOST SUITABLE FOR CLINICAL TRIALS OF AGENTS TARGETING LYMPHOPROLIFERATIONS

ARMAĞAN B., Robinson S., Bazoberry A., Grader-Beck T., Baer A.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1160, (Özet Bildiri) Creative Commons License identifier

17. APPLICATION OF AUTO-INFLAMMATORY DISEASE DAMAGE INDEX (ADDI) TO PATIENTS WITH FMF AND RELATED FACTORS WITH DAMAGE

BABAOĞLU H., ARMAĞAN B., Bodakci E., KAŞİFOĞLU T., Satis H., Atas N., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1005, (Özet Bildiri) Creative Commons License identifier

18. CLINICAL FEATURES OF ANEURYSMAL BEHCET DISEASE

ARMAĞAN B., BÖLEK E. Ç., SARI A., YARDIMCI G. K., Farisogullari B., BİLGİN E., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1182, (Özet Bildiri) Creative Commons License identifier

19. VALIDATION OF THE GIANT CELL ARTERITIS CLASSIFICATION CRITERIA IN TURKISH PATIENTS

ARMAĞAN B., YILDIRIM A., Onur M., Yardimci G., KILIÇ L., KALYONCU U., et al.
19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, (Özet Bildiri) identifier

20. VALIDITY OF ACR/EULAR 2017 PROVISIONAL CLASSIFICATION CRITERIA FOR ANCA-ASSOCIATED VASCULITIS IN TURKISH PATIENTS AND COMPARISON WITH 1990 CRITERIA

Yardimci G., BİLGİN E., ARMAĞAN B., Farisogullari B., KILIÇ L., AKDOĞAN A., et al.
19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, ss.39, (Özet Bildiri) identifier

21. Effectiveness of a Biopsychosocial Exercise Approach in Rheumatic Diseases

ÜNAL E., ARIN G., KARACA N. B., OFLAZ F. B., ÖZÇADIRCI A., ERDEN A., et al.
American College of Rheumatology, ACR Convergence-2018, Chicago, IL, Amerika Birleşik Devletleri, 19 - 24 Ekim 2018, (Tam Metin Bildiri)

22. BİLİŞSEL EGZERSİZ TERAPİ YAKLAŞIMI ÖLÇEĞİNİN ROMATOİD ARTRİT TANISI ALAN BİREYLERDE GEÇERLİĞİ, GÜVENİRLİĞİ VE DUYARLILIĞININ BELİRLENMESİ

OFLAZ F. B., KARACA N. B., ÖZÇADIRCI A., ARIN G., KARAKAYA KARABULUT J., ERDEN A., et al.
XIX. Ulusal Romatoloji Kongresi, Türkiye, 26 - 30 Eylül 2018, (Özet Bildiri)

23. Pulmonary manifestations of antiphospholipid syndrome: A retrospective analysis of 67 patients

SARINÇ ULAŞLI S., KÖKSAL D., KARCIOĞLU O., ARMAĞAN B., SARI A., BABAOĞLU E., et al.
28th International Congress of the European-Respiratory-Society (ERS), Paris, Fransa, 15 - 19 Eylül 2018, cilt.52, (Özet Bildiri) identifier

24. FOUR YEARS OF DELAY IN THE DIAGNOSIS OF SAPHO SYNDROME: SINGLE TERTIARY CENTRE EXPERIENCE

Erden A., Ekici M., Armagan B., Sari A., Yardimci G. K., Kilic L., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1552, (Özet Bildiri) Creative Commons License identifier

25. IS RELAPSE RATE OF GIANT CELL ARTERITIS IN REAL-LIFE EXPERIENCE LOWER THAN IN THE CONTROLLED TRIALS? RESULTS OF A RETROSPECTIVE, MULTI-CENTRE COHORT STUDY

Alibaz-Oner F., Balci M. A., Pamuk O. N., Zengin O., Tasci M., Dogru A., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1118-1119, (Özet Bildiri) Creative Commons License identifier

26. RETENTION RATES OF CERTOLIZUMAB PEGOL IN ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS PATIENTS: HUR-BIO REAL LIFE RESULTS

Armagan B., Sari A., Erden A., Yardimci G. K., Kilic L., Kalyoncu U., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1001-1002, (Özet Bildiri) Creative Commons License identifier

27. ASSOCIATION BETWEEN TISSUE OXYGEN DELIVERY AND DIGITAL ULCERS IN SYSTEMIC SCLEROSIS

Sari A., Sener Y. Z., Oksul M., Armagan B., Erden A., Kilic L., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.743, (Özet Bildiri) Creative Commons License identifier

28. FREQUENCY OF PULMONARY HYPERTENSION IN BEHCET'S DISEASE

Armagan B., Oksul M., Sener Y. Z., Sari A., Erden A., Yardimci G. K., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1471, (Özet Bildiri) Creative Commons License identifier

29. POLYARTERITIS NODOSA: OVER 20 YEARS' CLINICAL EXPERIENCE

Sonmez H. E., Armagan B., Ayan G., BARUT K., Batu E. D., Erden A., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.775-776, (Özet Bildiri) Creative Commons License identifier

30. INFLUENCE OF EPIDEMIOLOGY AND ETHNICITY ON SYSTEMIC EXPRESSION OF PRIMARY SJOGREN SYNDROME IN 9974 PATIENTS

Retamozo S., Acar-Denizli N., Ng W. F., Zeher M., Rasmussen A., Seror R., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.110, (Özet Bildiri) Creative Commons License identifier

31. ANTI-INTERLEUKIN-6 (TOCILIZUMAB) EXPERIENCE IN TAKAYASU'S ARTERITIS PATIENTS

Kilic L., Karadag O., Erden A., Sari A., Armagan B., Firat E., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.437-438, (Özet Bildiri) Creative Commons License identifier

32. COMPARISON OF CUT-OFF VALUES FOR FERRITIN TO DISCRIMINATE ADULT ONSET STILL'S DISEASE FROM OTHER CAUSES OF FEVER OF UNKNOWN ORIGIN: RESULTS OF A PROSPECTIVE STUDY

Bilgin E., Erden A., Armagan B., Kilic L., Sari A., Yardimci G., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1675, (Özet Bildiri) Creative Commons License identifier

33. PSAID-12 CAN BE USED TO DETERMINE THE ANTI-TNF TREATMENT DECISION IN THE PSORIATIC ARTHRITIS REGISTRY

Kalvoncu U., Kiraz S., Bilgen S. A., Karadag O., Akdogan A., Kilic L., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1601-1602, (Özet Bildiri) Creative Commons License identifier

34. A NORTH-SOUTH WORLDWIDE GRADIENT IN SYSTEMIC ACTIVITY OF PRIMARY SJOGREN SYNDROME: INCREASED SEVERE DISEASE IN PATIENTS FROM SOUTHERN COUNTRIES

Retamozo S., Acar-Denizli N., Ng W. F., Zeher M., Rasmussen A., Seror R., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1190, (Özet Bildiri) identifier

35. HOW TO DIFFERENTIATE ADULT ONSET STILL'S DISEASE FROM OVERALL OTHER CAUSES OF FEVER OF UNKNOWN ORIGIN: RESULTS OF A PROSPECTIVE STUDY FROM A TERTIARY REFERRAL CENTRE

BİLGİN E., Erden A., Armagan B., KILIÇ L., Sari A., YARDIMCI G. K., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1156-1157, (Özet Bildiri) Creative Commons License identifier

36. WHICH ONE IS MORE VALUABLE FOR DIAGNOSIS OF ADULT ONSET STILL'S DISEASE? SOLELY NEUTROPHILIA OR LEUKOCYTOSIS WITH NEUTROPHILIA?

Bilgin E., Erden A., Armagan B., Kilic L., Sari A., Yardimci G., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1150, (Özet Bildiri) Creative Commons License identifier

37. IDIOPATHIC GRANULOMATOUS MASTITIS MAY RESPONSE WELL TO COMBINATION OF IMMUNOSUPRESIVES AND GLUCOCORTICOIDS

Sari A., Konan A., Akpinar M., Armagan B., Erden A., Kilic L., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1152-1153, (Özet Bildiri) Creative Commons License identifier

38. ANKİLOZAN SPONDİLİT HASTALARINDA HASTALIK AKTİVİTESİ VE FONKSİYONELLİK ARASINDAKİ İLİŞKİNİN İNCELENMESİ

ARIN G., TÜRKMEN N. B., OFLAZ F. B., SARI A., ARMAĞAN B., KALYONCU U., et al.
3.Ulusal Romatolojik Rehabilitasyon Kongresi, Türkiye, 6 - 08 Ekim 2017, cilt.4, ss.22, (Özet Bildiri)

39. Starting of Biological Dmards May be Postponed in RA Patients with Multimorbidity: Single Centre Real Life Results

ARMAĞAN B., SARI A., ERDEN A., KILIÇ L., ERDAT E. C., KARADAĞ Ö., et al.
2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)

40. Older Age and Male Gender Are Independent Predictors of Quantiferon Positivity Among Adult Rheumatic Patients in a Tertiary Care Center from a BCG Vaccinated Country: Hur-BIO Single Center Real Life Results

ŞEYHOĞLU E., UYAROĞLU O. A., ERDEN A., KILIÇ L., ARMAĞAN B., SARI A., et al.
2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

41. Patients with Ankylosing Spondylitis Had Better Adalimumab Survival Than Patients with Non-Radiographic Axial Spondyloarthritis

SARI A., ARMAĞAN B., ERDEN A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., et al.
2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)

42. Which Definition Should be Used to Determine Colchicine Resistance in Patients with Familial Mediterranean Fever?

ERDEN A., BATU E. D., SARI A., SÖNMEZ H. E., ARMAĞAN B., FIRAT E., et al.
2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)

43. Pregnancy Outcomes in Male Patients Using Anti-Tumor Necrosis Factor Alpha Patients with Inflammatory Arthritis Hur-BIO Real Life Experiences

UYAROĞLU O. A., ŞEYHOĞLU E., ERDEN A., KILIÇ L., ARMAĞAN B., SARI A., et al.
2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)

44. A Retrospective Study Comparing the Phenotype and Outcomes of Patients with Polyarteritis Nodosa between UK and Turkish Cohorts

KARADAĞ Ö., ERDEN A., BİLGİNER Y., GOPALUNI S., SARI A., ARMAĞAN B., et al.
2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)

45. Blood Group ”a” Was Increased in FMF Patients and Blood Group ”0” May be Associated with Colchicine Resistance

ERDEN A., BATU E. D., ARMAĞAN B., SÖNMEZ H. E., SARI A., DEMİR S., et al.
ARTHRITIS RHEUMATOLOGY, 19 - 24 Ekim 2017, (Tam Metin Bildiri)

46. PS 121- BAŞ BOYUN TÜMÖRÜNÜ TAKLİT EDEN WEGENER GRANÜLOMATOZ OLGUSU

DURMAZ H., ARMAĞAN B., SARI A., ERDEN A., AKDOĞAN A., ÖZTÜRK H.
19. Ulusal İç Hastalıkları Kongresi, Antalya, Türkiye, 11 - 15 Ekim 2017, (Özet Bildiri)

47. A Section of Rare Diseases in Hacettepe Adult Clinics in Rheumatology: Deficiency of Adenosine Deaminase 2 (DADA2)

BÖLEK E. Ç., ERDEN A., ÖZEN S., KARADAĞ Ö., KALYONCU U., BATU E. D., et al.
5th Rare Diseases Summer School, 7 - 09 Haziran 2017, (Tam Metin Bildiri)

48. EVALUATION OF VITAMIN B12 DEFICIENCY AND ASSOCIATED FACTORS IN PATIENTS WITH SYSTEMIC SCLEROSIS

Kilic D. T., Sari A., Armagan B., Erden A., Kilic L., Kilinckaya M., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.637-638, (Özet Bildiri) Creative Commons License identifier

49. ARE THE DEMOGRAPHIC AND CLINICAL FEATURES OF POLYARTERITIS NODOSA SIMILAR BETWEEN THE UK AND TURKEY?

Karadag O., Erden A., Batu E. D., Gopaluni S., Sari A., Armagan B., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.329, (Özet Bildiri) Creative Commons License identifier

50. ABATACEPT EXPERIENCE IN BIOLOGIC NAIVE RHEUMATOID ARTHRITIS PATIENTS: HUR-BIO REAL LIFE RESULTS

Sari A., Armagan B., Kilic L., Erden A., Karadag O., Akdogan A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.854-855, (Özet Bildiri) Creative Commons License identifier

51. THE USE OF RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: IN WHICH INFUSION INTERVALS WERE GIVEN AND HOW DID THEY RESPOND? HUR-BIO REAL LIFE RESULTS

Armagan B., Sari A., Erden A., Kilic L., Karadag O., Akdogan A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1194-1195, (Özet Bildiri) Creative Commons License identifier

52. FUNCTIONAL DISABILITY IN RA PATIENTS TREATED WITH BIOLOGICS: HUR-BIO REAL LIFE RESULTS

Sari A., Armagan B., Erden A., Kilic L., Karadag O., Akdogan A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1127, (Özet Bildiri) Creative Commons License identifier

53. . IGG4-RELATED DISEASE IN EASTERN MEDITERRANEAN: CLINICAL FEATURES AND OUTCOMES OF A LARGE COHORT

KARADAĞ Ö., ERDEN A., AYHAN E. A., BÖLEK E. Ç., ARMAĞAN B., KILIÇ L., et al.
EULAR 2017, 6 - 10 Haziran 2017, cilt.76, ss.720, (Özet Bildiri) Creative Commons License identifier

54. RAID COMPOSITE INDEX IN THE EVALUATION OF RA PATIENTS RECEIVING BIOLOGICAL TREATMENT: HUR-BIO REAL-LIFE RESULTS

Erden A., Kilic L., Armagan B., Sari A., Akdogan A., Bilgen S. A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1113, (Özet Bildiri) Creative Commons License identifier

55. QUANTIFERON (R)-TB GOLD IN-TUBE ASSAY CAN BE USED FOR LATENT TUBERCULOSIS SCREENING BEFORE BIOLOGICAL DRUG TREATMENT IN A BCG VACCINATED COUNTRY: HUR-BIO SINGLE CENTER REAL LIFE RESULTS

Seyhoglu E., Uyaroglu O. A., Erden A., Kilic L., Armagan B., Sari A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1412-1413, (Özet Bildiri) Creative Commons License Sürdürülebilir Kalkınma identifier

56. THERE IS A COMMUNICATION PROBLEM BETWEEN PATIENT AND PHYSICIAN DURING PRE-CONCEPTIONAL PERIOD: HUR-BIO REAL LIFE RESULTS

Uyaroglu O. A., Seyhoglu E., Erden A., Kilic L., Armagan B., Sari A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.448, (Özet Bildiri) Creative Commons License identifier

57. RITUXIMAB EXPERIENCE IN PATIENTS WITH LONGSTANDING SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: A SERIES OF 14 PATIENTS

Sari A., Guven D., Armagan B., Kilic L., Erden A., Akdogan A.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1262-1263, (Özet Bildiri) Creative Commons License identifier

58. BIOLOGICAL THERAPY IN NON-SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS PATIENTS FOLLOWED IN ADULT RHEUMATOLOGY DEPARTMENT: HUR-BIO REAL LIFE RESULTS

Kilic L., Sari A., Armagan B., Erden A., Karadag O., Akdogan A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.402, (Özet Bildiri) Creative Commons License identifier

59. RESULTS OF SCREENING FOR VIRAL HEPATITIS IN RA PATIENTS TREATED WITH BIOLOGICS: HUR-BIO REAL LIFE RESULTS

Sari A., Armagan B., Erden A., Kilic L., Akdogan A., Bilgen S. A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1175, (Özet Bildiri) Creative Commons License Sürdürülebilir Kalkınma identifier

60. ANKYLOSING SPONDYLITIS PATIENTS WITH UVEITIS HAD BETTER ADALIMUMAB RETENTION RATE: HUR-BIO REAL LIFE RESULTS

Armagan B., Sari A., Erden A., Kilic L., Guven D. C., Pashayev T., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1300-1301, (Özet Bildiri) Creative Commons License identifier

61. COMORBIDITY AND SURGERY HISTORY OF RHEUMATOID ARTHRITIS PATIENTS WHO ARE RECEIVING BIOLOGICAL AGENT

Armagan B., Sari A., Erden A., Kilic L., Erdat E. C., Karadag O., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.534, (Özet Bildiri) Creative Commons License identifier

62. WIDE HETEROGENEITY IN TREATMENT PROTOCOLS AND INAPPROPIATE USE OF PREDNISOLONE FOR ANTI-RO/LA ASSOCIATED-CONGENITAL HEART BLOCK: A SYSTEMATIC REVIEW OF 492 CASES

Erden A., Kilic L., Bilgin E., Fanouriakis A., Ceylan S., Hyrnabaccus B., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1215-1216, (Özet Bildiri) Creative Commons License identifier

63. PREMATURE CORONARY HEART DISEASE FREQUENCY IN RHEUMATOID ARTHRITIS WHO ARE RECEIVING BIOLOGIC AGENTS: HUR-BIO REAL LIFE RESULTS

Armagan B., Sari A., Erden A., Kilic L., Erdat E. C., Karadag O., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.250-251, (Özet Bildiri) Creative Commons License identifier

64. ADHERENCE OF RHEUMATIC PATIENTS TO INH PROPHYLAXIS PRESCRIBED BEFORE BIOLOGICAL TREATMENT: HUR-BIO SINGLE CENTER REAL LIFE RESULTS

Seyhoglu E., Uyaroglu O. A., Erden A., Kilic L., Armagan B., Sari A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1035, (Özet Bildiri) Creative Commons License identifier

65. PSORIASIS IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER

Erden A., Batu E. D., Bilgin E., Sonmez H. E., Seyhoglu E., Demir S., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.414, (Özet Bildiri) identifier

66. THORAX CT FINDINGS IN A LARGE COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS: HUR-BIO REAL LIFE RESULTS

Sari A., Armagan B., Erden A., Kilic L., Karadag O., Akdogan A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.256, (Özet Bildiri) Creative Commons License identifier

67. Comorbidity and Surgery History of Rheumatoid Arthritis Patients Who Receiving Biological Agent

ARMAĞAN B., SARI A., ERDEN A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., et al.
MIRCIM 2017 TIHUD-TIP JOINT MEETING, Krakow, Polonya, 11 - 14 Mayıs 2017, (Özet Bildiri)

68. LEUKOCYTOCLASTIC VASCULITIS IN THE BONE MARROW

SARI A., ARMAĞAN B., ERDEN A., KILIÇ L., Ayhan A. S., KARADAĞ Ö.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.72, (Özet Bildiri) identifier

69. SCALP NECROSIS IN NEUROFIBROMATOSIS TYPE-1 VASCULOPATHY: A DIAGNOSTIC DILEMMA

Guven D., SARI A., ARMAĞAN B., KİRAZ S., KILIÇ L., KARADAĞ Ö., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.101-102, (Özet Bildiri) identifier

70. EVALUATION OF ASSSOCIATION BETWEEN ANTIPHOSPHOLIPID ANTIBODIES OR LUPUS ANTICOAGULANT POSITIVITY AND SEVERITY OF VASCULAR INVOLVEMENT IN TAKAYASU ARTERITIS PATIENTS

FIRAT E., ERDEN A., SARI A., ARMAĞAN B., KILIÇ L., KALYONCU U., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.48, (Özet Bildiri) identifier

71. TWO-YEAR RESULTS OF A PROSPECTIVE VASCULITIS COHORT FROM EASTERN MEDITERRANEAN: DEMOGRAPHIC CHARACTERISTICS AND DISTRIBUTION OF THE VASCULITIDES FREQUENCIES

KARADAĞ Ö., APRAŞ BİLGEN Ş. Ş., ARMAĞAN B., SARI A., ERDEN A., BATU AKAL E. D., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, (Özet Bildiri) identifier

72. SUCCESSFUL TREATMENT OF AORTOENTERIC FISTULA A PATIENT WITH BEHCET DISEASE INTERFERON ALFA2A AND SURGERY

ARMAĞAN B., SARI A., ERDEN A., KILIÇ L., KALYONCU U., KARADAĞ Ö.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.94, (Özet Bildiri) identifier

73. RITUXIMAB SEEMS OUTSTANDING BIOLOGICAL OPTION IN LATE ONSET RHEUMATOID ARTHRITIS: HUR-BIO REAL LIFE RESULTS

Kilic L., Erden A., Sari A., Armagan B., Karadag O., Akdogan A., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.1022-1023, (Özet Bildiri) identifier

74. DEMOGRAPHIC CHARACTERISTICS AND DISTRIBUTION OF THE VASCULITIDES FREQUENCIES: A REAL-LIFE EXPERIENCE OF VASCULITIS CENTER FROM EASTERN MEDITERRANEAN

Karadag O., Erden A., Bilgin E., Batu E. D., Armagan B., Sari A., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.1096-1097, (Özet Bildiri) identifier

75. COMMON AND UNCOMMON MANIFESTATIONS OF GRANULOMATOSIS WITH POLIANGIITIS (GPA) AT CHEST CT: A VASCULITIS CENTER EXPERIENCE

Taydas O., Kilic L., Atceken Z., Erden A., Armagan B., Sari A., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.796, (Özet Bildiri) identifier

76. DAPSA WITH TWENTY-EIGHT JOINT COUNTS MAY BE USEFUL FOR THE ASSESSMENT OF PSORIATIC ARTHRITIS

Kalyoncu U., Erden A., Kilic L., Sari A., Armagan B., Karadag O., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.1159-1160, (Özet Bildiri) identifier

77. DEMOGRAPHIC, CLINIC AND LABORATORY FEATURES OF 755 PATIENTS WITH NEONATAL LUPUS ERYTHEMATOSUS: SYSTEMATIC REVIEW

Erden A., Kilic L., Bilgin E., Ceylan S., Hymabaccus B., Sener Y. Z., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.874, (Özet Bildiri) identifier

78. COMPARING THE CHARACTERISTICS OF ADULT AND PEDIATRIC PATIENTS WITH POLYARTERITIS NODOSA

Erden A., Batu E. D., Bilgin E., Sonmez H. E., Armagan B., Sari A., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.799, (Özet Bildiri) identifier
Kitaplar 1

1. PATOFİZYOLOJİNİN TEMELLERİ

DURUSU TANRIÖVER M., SARI A., EŞME M., KOÇ YILDIRIM S., YILDIRIM M. Ş., BÖLEK E. Ç., et al.
PALME YAYINCILIK, 2017
Metrikler

Yayın

184

Yayın (WoS)

168

Yayın (Scopus)

103

Atıf (WoS)

247

H-İndeks (WoS)

7

Atıf (Scopus)

392

H-İndeks (Scopus)

12

Proje

1

Açık Erişim

64
BM Sürdürülebilir Kalkınma Amaçları